Fuji Pharma Co., Ltd. (TYO:4554)

Revenue by Segment

Financials in millions JPY. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Pharmaceutical Business	51.68B	46.14B	40.89B	35.43B	33.99B
Pharmaceutical Business Growth	12.01%	12.84%	15.42%	4.22%	0.58%
Total	51.68B	46.14B	40.89B	35.43B	33.99B
Total Growth	12.01%	12.84%	15.42%	4.22%	0.58%

Revenue by Geography

Financials in millions JPY. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Japan	51.68B	46.14B	40.89B	35.43B	33.99B
Japan Growth	12.01%	12.84%	15.42%	4.22%	0.58%
Total	51.68B	46.14B	40.89B	35.43B	33.99B
Total Growth	12.01%	12.84%	15.42%	4.22%	0.58%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error